2023-503398-39-00RecruitingPhase 2
IMPROCAS - Improved Prediction of Ovarian Cancer Surgery
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this project is to investigate nuclear magnetic resonance (NMR)-derived metabolomics from blood samples, functional and metabolic MRI techniques and their ability to improve ovarian cancer diagnostics. Based on the above, a model able to identify ovarian cancer and improve the accuracy of correct diagnosis and disease severity will be proposed.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 13 Jul 2023
- Start date
- 1 Mar 2024
- Lead sponsor
- Aarhus University
- Diseases
- Ovarian cancer
- EU CT number
- 2023-503398-39-00
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 40
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe renovascular disease
- Any other malign disease or recidiv of a former malign disease present within the last 3-5 years (except benign basal basocelluar carcinoma (BBC))
- Allergy to pyruvate
Lab values
- Contraindications for MRI with contrast: - eGFR less than 30 ml/min/1.73m2 - Severe unstable asthma - Pacemaker, implantable cardiac defibrillator, neurostimulator or cochlear implant - Metal foreign bodies such as fragments and irremovable piercings - Unsafe medical implants (safety of heart valves, hips and the like must be confirmed) - Claustrophobia - Largest circumference including arms > 160 cm
Other
- Substantial cognitive disability that would influence the patients’ ability to either give truly informed consent or listen to / comply with safety-related instructions.
- Pregnancy
Who the study is looking for
- Suspected epithelial ovarian cancer (and referred to dept. of Gynaecology and Obstetrics, AUH)
- Understanding Danish
- Age 18 – 85 years
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus Universitet | Aarhus N | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.